Filing Details
ProPhase Labs, Inc. (NASDAQ:PRPH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on June 30, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:PRPH
ProPhase Labs, Inc. (PRPH) Files Quarterly Report for Q0
Filing Details ProPhase Labs, Inc. (NASDAQ:PRPH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on June 30, 2026. The Healthcare company…
Market Context
ProPhase Labs, Inc.'s stock currently trades at $0.09 with a market capitalization of $6.3M.
The 10-Q provides ProPhase Labs, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for ProPhase Labs, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PRPH Stock Page
Frequently Asked Questions
Where can I read PRPH's SEC filings?
Browse all filings on our PRPH SEC filings page.
What types of SEC filings does ProPhase Labs, Inc. file?
Public companies like ProPhase Labs, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.